Pleiotropic cell-division defects and apoptosis induced by interference with survivin function-Reference-Cited by-同舟云学术

Pleiotropic cell-division defects and apoptosis induced by interference with survivin function

Published:1999-10-27 Issue:8 Volume:1 Page:461-466
ISSN:1465-7392
Container-title:Nature Cell Biology
language:en
Short-container-title:Nat Cell Biol

Author:

Li Fengzhi,Ackermann Elizabeth J.,Bennett C. Frank,Rothermel Annette L.,Plescia Janet,Tognin Simona,Villa Antonello,Marchisio Pier Carlo,Altieri Dario C.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology

Link

http://www.nature.com/articles/ncb1299_461.pdf

Reference35 articles.

1. Vaux, D. L. & Korsmeyer, S. J. Cell death in development. Cell 96, 245–254 (1999).

2. Raff, M. Cell suicide for beginners. Nature 396, 119–122 (1998).

3. Evan, G. & Littlewood, T. A matter of life and cell death. Science 281, 1317–1322 (1998).

4. Linette, G. P., Li, Y., Roth, K. & Korsmeyer, S. J. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc. Natl Acad. Sci. USA 93, 9545–9552 (1996).

5. Minn, A. J., Boise, L. H. & Thompson, C. B. Expression of Bcl-XL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev. 10, 2621–2631 (1996).

Cited by 525 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Graphene-Based Photodynamic Therapy and Overcoming Cancer Resistance Mechanisms: A Comprehensive Review;International Journal of Nanomedicine;2024-06

2. Survivin as a Therapeutic Target for the Treatment of Human Cancer;Cancers;2024-04-27

3. An Active Compound from the Pyrazine Family Induces Apoptosis by Targeting the Bax/Bcl2 and Survivin Expression in Chronic Myeloid Leukemia K562 Cells;Anti-Cancer Agents in Medicinal Chemistry;2024-02

4. Halofilins as Emerging Bactofilin Families of Archaeal Cell Shape Plasticity Orchestrators;2024-01-23

5. Inhibition of survivin by 2′-O-methyl phosphorothioate-modified steric-blocking antisense oligonucleotides;RSC Advances;2024